Scaffold Biotech
Scaffold Biotech is a biotechnology company focused on protein engineering to create next-generation subunit vaccines. Their mission is to advance protein engineering to develop solutions for human, animal, and environmental health. Their vision is to bring innovative vaccinology solutions from computer design to market. The company utilizes modular protein scaffold technologies for maximum immune response. Their process involves bioinformatics analysis for antigen selection, AI-driven in silico optimization for improved immunogenicity and stability, high-yield recombinant antigen production, and functional enhancement by coupling antigens to protein scaffolds. They are currently developing an anti-tick nanovaccine with high efficacy and broad-spectrum protection for livestock, addressing the significant economic losses caused by ticks and tick-borne diseases. This vaccine offers advantages such as being safe, eco-friendly, easily implementable, potent, versatile, adaptable, and produced with high quality and stability. The vaccine works by generating protective antibodies in cattle, which then damage ticks feeding on them, reducing engorgement and egg-laying. Seasonal boosts are needed to maintain protection.
Scaffold Biotech
Scaffold Biotech is a biotechnology company focused on protein engineering to create next-generation subunit vaccines. Their mission is to advance protein engineering to develop solutions for human, animal, and environmental health. Their vision is to bring innovative vaccinology solutions from computer design to market. The company utilizes modular protein scaffold technologies for maximum immune response. Their process involves bioinformatics analysis for antigen selection, AI-driven in silico optimization for improved immunogenicity and stability, high-yield recombinant antigen production, and functional enhancement by coupling antigens to protein scaffolds. They are currently developing an anti-tick nanovaccine with high efficacy and broad-spectrum protection for livestock, addressing the significant economic losses caused by ticks and tick-borne diseases. This vaccine offers advantages such as being safe, eco-friendly, easily implementable, potent, versatile, adaptable, and produced with high quality and stability. The vaccine works by generating protective antibodies in cattle, which then damage ticks feeding on them, reducing engorgement and egg-laying. Seasonal boosts are needed to maintain protection.